VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
HCAT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
HCATHealth Catalyst, Inc.
$1.46$108M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksHCATQuarterly Financials

Health Catalyst, Inc. (HCAT) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Health Catalyst, Inc. (HCAT) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

HCAT Income Statement

Quarterly statement

HCAT Income Statement

Health Catalyst, Inc. (HCAT) annual income statement — 9-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Sales/Revenue56.28M70.49M70.76M74.68M76.32M80.72M79.41M79.61M76.35M75.9M74.72M75.08M73.77M73.21M73.87M69.16M68.35M70.63M68.09M64.72M
Revenue Growth %-26.26%-12.68%-10.9%-6.19%-0.04%6.35%6.28%6.02%3.5%3.67%1.16%8.56%7.93%3.65%8.49%6.87%10.72%18.46%21.92%21.47%
Cost of Goods Sold32.24M35.63M47.1M35.3M38.51M42.48M43.18M44.91M42.31M40.06M38.52M44.58M41.79M39.44M38.3M38.11M36.34M34.61M34M33.88M
COGS % of Revenue57.29%50.54%66.57%47.26%50.45%52.63%54.37%56.42%55.42%52.78%51.55%59.37%56.64%53.87%51.85%55.1%53.16%49%49.93%52.35%
Gross Profit24.04M34.86M23.66M39.38M37.82M38.24M36.23M34.69M34.04M35.84M36.21M30.51M31.99M33.77M35.56M31.06M32.01M36.03M34.09M30.84M
Gross Margin %42.71%49.46%33.43%52.74%49.55%47.37%45.63%43.58%44.58%47.22%48.45%40.63%43.36%46.13%48.15%44.9%46.84%51%50.07%47.65%
Gross Profit Growth %-36.43%-8.84%-34.71%13.53%11.09%6.69%0.08%13.71%6.42%6.12%1.81%-1.76%-0.09%-6.25%4.32%0.7%11.74%21.82%19.58%15.28%
Operating Expenses30.07M71.34M30.41M36.12M55.33M75.33M56.41M52.19M47.73M51.65M59.02M63.29M56.57M68.39M70.48M67.8M77.73M69.22M58.44M75.6M
OpEx % of Revenue53.42%101.21%42.97%48.37%72.49%93.33%71.03%65.56%62.51%68.05%78.98%84.3%76.68%93.42%95.41%98.03%113.72%98%85.83%116.82%
Selling, General & Admin20.56M22.29M24.55M13.33M30.43M21.49M28.9M26.92M23.55M27.11M33.62M32.7M26.92M40.07M42.4M36.52M44.59M38.46M29.64M47.2M
SG&A % of Revenue36.53%31.62%34.69%17.85%39.87%26.62%36.39%33.82%30.84%35.71%45%43.55%36.49%54.73%57.4%52.81%65.24%54.45%43.53%72.94%
Research & Development9.5M11.03M9.67M9.91M12.28M12.39M15.19M15M14.19M13.88M14.87M20.29M17.67M17.59M17.08M19.61M20.77M18.15M17.15M17.48M
R&D % of Revenue16.88%15.64%13.67%13.27%16.09%15.35%19.12%18.85%18.59%18.29%19.9%27.02%23.95%24.03%23.13%28.36%30.39%25.69%25.19%27.01%
Other Operating Expenses01000K-1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K
Operating Income50.14M-36.48M-6.75M3.26M-17.51M-37.09M-20.17M-17.5M-13.69M-15.81M-22.81M-32.78M-24.58M-34.62M-34.91M-36.74M-45.72M-33.19M-24.35M-44.77M
Operating Margin %89.08%-51.75%-9.54%4.37%-22.94%-45.95%-25.4%-21.98%-17.93%-20.83%-30.53%-43.66%-33.32%-47.28%-47.27%-53.13%-66.89%-46.99%-35.76%-69.17%
Operating Income Growth %386.35%1.66%66.55%118.63%-27.92%-134.67%11.58%46.62%44.32%54.34%34.66%10.78%46.24%-4.3%-43.4%17.92%-8.22%-2.7%-0.12%-15.01%
EBITDA59.87M-25.5M5.37M16.14M-4.89M-24.41M-7.85M-7.23M-3.7M-5.15M-12.29M-22.48M-13.65M-23.88M-23.16M-24.31M-32.55M-19.95M-12.55M-33.84M
EBITDA Margin %106.36%-36.18%7.59%21.62%-6.41%-30.24%-9.89%-9.09%-4.85%-6.79%-16.44%-29.94%-18.51%-32.62%-31.35%-35.15%-47.62%-28.25%-18.44%-52.29%
EBITDA Growth %1322.98%-4.47%168.36%323.15%-32.15%-373.98%36.1%67.82%72.87%78.44%46.94%7.52%58.05%-19.71%-84.44%28.17%-3.02%17.49%23.92%-8.64%
D&A (Non-Cash Add-back)9.73M10.98M12.12M12.88M12.61M12.68M12.32M10.27M9.98M10.66M10.53M10.3M10.93M10.73M11.76M12.44M13.17M13.24M11.79M10.92M
EBIT0-40.22M-105.87M-85.13M-16.55M-35.11M-16.21M-12.75M-16.71M-11.61M-18.64M-28.34M-20.15M-30.71M-31.3M-33.91M-43.77M-32.56M-24.2M-44.59M
Net Interest Income0-3.72M-3.94M-4.61M-4.5M-4.13M-3.48M-2.45M-1.39M2.38M2.36M2.6M2.63M2.08M1.79M1.05M165K-1.13M-1.63M-4.39M
Interest Income0924K798K909K1.14M1.66M3.83M4.85M4.74M4.21M4.19M4.42M4.46M3.9M3.6M2.86M1.98M676K174K162K
Interest Expense-540K4.64M4.74M5.52M5.63M5.79M7.32M7.3M6.13M1.83M1.83M1.83M1.82M1.82M1.82M1.81M1.81M1.81M1.8M4.55M
Other Income/Expense-10.03M-3.74M-103.86M-93.91M-4.68M-3.8M-3.36M-2.55M-1.51M2.36M2.34M2.62M2.61M2.09M1.79M1.02M142K-1.18M-1.66M-4.38M
Pretax Income40.1M-40.22M-110.61M-90.65M-22.19M-40.9M-23.53M-20.05M-15.2M-13.45M-20.47M-30.17M-21.97M-32.53M-33.12M-35.72M-45.58M-34.37M-26.01M-49.14M
Pretax Margin %71.25%-57.06%-156.33%-121.38%-29.07%-50.66%-29.63%-25.18%-19.91%-17.71%-27.4%-40.18%-29.78%-44.43%-44.84%-51.65%-66.68%-48.66%-38.2%-75.93%
Income Tax393K315K414K379K41K81K215K625K-475K70K113K143K59K85K69K59K156K-944K-3.55M-149K
Effective Tax Rate %0.98%-0.78%-0.37%-0.42%-0.18%-0.2%-0.91%-3.12%3.12%-0.52%-0.55%-0.47%-0.27%-0.26%-0.21%-0.17%-0.34%2.75%13.65%0.3%
Net Income40.5M-40.54M-111.03M-91.03M-22.23M-40.98M-23.74M-20.67M-14.73M-13.52M-20.59M-30.31M-22.03M-32.61M-33.19M-35.78M-45.73M-33.43M-22.46M-48.99M
Net Margin %71.95%-57.51%-156.91%-121.89%-29.12%-50.77%-29.9%-25.97%-19.29%-17.81%-27.55%-40.37%-29.86%-44.55%-44.93%-51.74%-66.91%-47.33%-32.98%-75.7%
Net Income Growth %282.18%1.08%-367.64%-340.31%-50.95%-203.18%-15.33%31.8%33.16%58.56%37.97%15.29%51.83%2.44%-47.79%26.96%-14.3%6.71%20.84%-13.89%
Net Income (Continuing)40.5M-40.54M-111.03M-91.03M-22.23M-40.98M-23.74M-20.67M-14.73M-13.52M-20.59M-30.31M-22.03M-32.61M-33.19M-35.78M-45.73M-33.43M-22.46M-48.99M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)0.53-0.55-1.53-1.28-0.32-0.59-0.35-0.33-0.24-0.23-0.35-0.53-0.39-0.58-0.60-0.66-0.84-0.62-0.42-0.94
EPS Growth %265.63%6.78%-337.14%-287.88%-33.33%-156.52%0%37.74%38.46%60.34%41.67%19.7%53.57%6.45%-42.86%29.79%-2.44%22.5%35.38%6.93%
EPS (Basic)0.54-0.55-1.53-1.28-0.32-0.59-0.35-0.33-0.24-0.23-0.35-0.53-0.39-0.58-0.60-0.66-0.84-0.62-0.42-0.94
Diluted Shares Outstanding75.93M73.96M72.59M71M70.38M69.63M68.55M62.38M60.44M59.3M58.59M57.48M56.71M55.98M55.48M54.5M54.3M53.67M53.22M52.12M
Basic Shares Outstanding75.39M73.96M72.59M71M70.38M69.63M68.55M62.38M60.44M59.3M58.59M57.48M56.71M55.98M55.48M54.5M54.3M53.67M53.01M52.12M
Dividend Payout Ratio--------------------